Riskpilot← Back to searchSign inGet full accessHELSEHUSET UTVIKLING AS
ASActiveOrg 924753668Myhrersvingen 12, 2080 EidsvollRental and operating of own or leased real estate · NACE 6820Est. 20200 employees
Revenue 2024
NOK 0
EBITDA margin
—
-57% vs 2023
Equity ratio
-24.2%
Financial strength
Net profit 2024
NOK -1,7M
-19% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -67K | -57% |
| Net profit | NOK -1,7M | -19% |
| Total assets | NOK 17,3M | +4% |
| Equity | NOK -4,2M | -65% |
| Employees | 0 | — |
Legal name
HELSEHUSET UTVIKLING AS
Org number
924753668
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
13. mars 2020
Share capital
NOK 300 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Å investere i fast eiendom eller selskaper som eier fast eiendom, samt utvikling, utleie og salg av egne eiendommer og selskaper og alt som dermed står i forbindelse.
Address
Myhrersvingen 12, 2080 Eidsvoll
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −24 | −40 | −47 | −43 | −67 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −24 | −40 | −47 | −43 | −67 |
| Net financials | 484 | −722 | −842 | −1 345 | −1 583 |
| Profit before tax | −508 | −763 | −889 | −1 388 | −1 651 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −508 | −763 | −889 | −1 388 | −1 651 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 17 054 | 17 020 | 16 642 | 16 628 | 17 332 |
| Equity | 61 | −645 | −1 534 | −2 539 | −4 190 |
| Long-term debt | 10 000 | 10 250 | 10 125 | 10 125 | 9 756 |
| Short-term debt | 6 993 | 7 415 | 8 051 | 9 043 | 11 766 |
| Total debt | 16 993 | 17 665 | 18 176 | 19 168 | 21 522 |
EBITDA margin
-6732700.0%
This company
15.8%
Market median
-42612125% vs market
20202024
Equity ratio
-24.2%
This company
38.2%
Market median
-163% vs market
20202024
Return on equity
-165063100.0%
This company
18.4%
Market median
-897082165% vs market
20202024
Net profit margin
-165063100.0%
This company
8.1%
Market median
-2037816149% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
5.14×
This company
0.62×
Market median
-729% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-02-28 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NF Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2022 | |
| Company | 33.33% | 33.33% | 2022 | |
| Company | 33.33% | 33.33% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Assura As
HELSEHUSET UTVIKLING AS Board members of HELSEHUSET UTVIKLING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Fredrik Jegersberg | Chief Executive Officer | 0 companies |
| Lars Kjell Tomren | Chairman | 0 companies |
| Nicolai Christian Walter Van Der Lagen | Board of Directors | 0 companies |